BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.525
-0.005 (-0.20%)
Feb 25, 2026, 4:00 PM EST - Market closed
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $5.97 million as of February 25, 2026. Its market cap has decreased by -13.72% in one year.
Market Cap
5.97M
Enterprise Value
3.37M
1-Year Change
-13.72%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $5.97M, a decrease of -85.83%. That is a compound annual growth rate of -30.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 5.98M | -35.95% |
| Dec 31, 2025 | 9.34M | 85.79% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Core Molding Technologies | 165.15M |
| Aemetis | 93.57M |
| Northern Technologies International | 85.90M |
| 5E Advanced Materials | 71.40M |
| Flexible Solutions International | 67.05M |
| Loop Industries | 62.84M |
| SenesTech | 11.23M |
| J-Star Holding | 10.20M |